Akebia Therapeutics, Inc. , a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.
Akebia Therapeutics stock last closed at $1.10, up 0.92% from the previous day, and has increased 206.41% in one year. It has overperformed other stocks in the Biotechnology industry by 2.19 percentage points. Akebia Therapeutics stock is currently +356.43% from its 52-week low of $0.24, and -32.52% from its 52-week high of $1.63.
As of Jun 2, 2023, there are 185.93M shares of AKBA outstanding. The market capitalization of AKBA is $204.52M. In the last 24 hours, 1.75M AKBA shares were traded.
How to Buy Akebia Therapeutics Stock
Not sure how to invest in Akebia Therapeutics stock? Here's how.
Decide where to buy Akebia Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you figure out where to buy Akebia Therapeutics stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit funds into your investment account: Select your method of payment and add your details.
Evaluate Akebia Therapeutics stock: The Akebia Therapeutics ticker symbol is AKBA. Is Akebia Therapeutics stock a good investment? Should you buy shares of AKBA? How do AKBA's underlying business fundamentals look? Do top analysts think Akebia Therapeutics is a good buy? Why has AKBA's stock price moved recently? (Hint: Our stock market research website can help you evaluate if AKBA is a good stock to buy).
Make your AKBA buy order: Decide if you will purchase AKBA shares at the current market price or use a limit order to purchase AKBA shares at a particular price.
Keep tabs on your AKBA position: Create a watchlist to keep tabs on your investment in Akebia Therapeutics shares.
Step 1: Decide where to buy Akebia Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy AKBA stock.
A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
In our opinion, eToro is the best brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to global markets: From Technology to Energy, New York to Tokyo — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal details so you are able to buy AKBA stock today.
Once you have chosen the best place to buy Akebia Therapeutics stock, it's critical to research their stock before you buy, so you truly comprehend the risk and opportunity.
Overview of key AKBA info
AKBA Price
$1.10
1w %
-2.65%
1y %
206.41%
5y %
-88.51%
P/E
-3.67x
P/B
-14.25x
P/S
0.75x
PEG
N/A
Revenue
$271.03M
Earnings
-$56.36M
Fore. Rev. Growth
-27.83%
Fore. Earn. Growth
N/A
Market Cap
$204.52M
Next Earnings
Aug 2, 2023
Next Dividend
N/A
AKBA Zen Score
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis.
AKBA has $56.95M in cash and short term investments. This is sufficient to cover its annual cash burn of $69.07M.
AKBA profit margin has gone up from -123.6% to -20.8% in the past year.
There are more short-term assets than short-term liabilities on the AKBA balance sheet.
Cons:
There are more long-term liabilities than short-term assets on the AKBA balance sheet.
AKBA debt to equity ratio of -20.29 is negative.
AKBA has cash burn of 69072000. It does not have sufficient cash and short-term investments to cover this.
Total AKBA debt is still negative.
Is AKBA stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 2 Wall Street analysts who give ratings on AKBA, the consensus analyst rating on AKBA is a Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
Most Recent AKBA Analyst Recommendations
Ed Arce, a top 9% analyst from HC Wainwright & Co. reiterates AKBA with a hold rating and maintains their AKBA price target from $2.00 to $2.00, on Jun 2, 2023.
Christopher Raymond, a top 24% analyst from Piper Sandler upgrades AKBA to a strong buy rating and raises their AKBA price target from $2.00 to $4.00, on May 31, 2023.
Last year, AKBA revenue was $271.03M. In the past five year, AKBA's revenue has gone up by 5.61% per year. This was slower than the Biotechnology industry average of 90.44%.
No, Akebia Therapeutics doesn't provide an income stream by paying out dividends.
AKBA Social Trading Data
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your AKBA buy order
You have two main options:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are generally the easiest way to buy.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at a given dollar amount, use a limit order.
Hit the Open Trade button and eToro will execute your order.
If you require more info about investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Akebia Therapeutics share?
As of Jun 2, 2023, it costs $1.10 to buy one share of Akebia Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.55, you can buy 0.5 shares of AKBA.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.